Australian regulator has no issues with Apotex drugs banned by FDA; GSK invests in continuous manufacturing;

> The Therapeutic Goods Administration in Australia says it is aware of bans on Apotex products in the U.S. and Canada but believes the drugs meet its standards. Story

> GlaxoSmithKline ($GSK) said that its new continuous manufacturing facility in Singapore should be operational by Q1 2016. Report

> Dr. Reddy's Laboratories is launching in the U.S. its generic of Pfizer's ($PFE) immunosuppressant Rapamune. Report

> Alembic Pharmaceuticals has taken a 49% interest in a joint venture with with Algerian-based AdwiyaMami, which has a plant that can produce 1.2 billion oral solids a year and has room for expansion. Report